Genmab A/S ( GMAB) - Stock Earnings
GMAB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026 AfterMarket | — / — | — | — / — | — |
GMAB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 401.0 million USD | 1.0 billion USD |
| 2025Q4 | 30.9 million USD | 1.1 billion USD |
| 2026Q1 | 53.2 million USD | 899.3 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
GMAB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.4 billion USD | 16.5 billion USD |
| 2024 | 7.8 billion USD | 21.5 billion USD |
| 2025 | 963.8 million USD | 3.7 billion USD |
| 2026 Est. | — | — |
GMAB
Price: $25.15
52 week price:
Earnings Per Share: 1.31 USD
P/E Ratio: 20.27
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 221594
Market Capitalization: 15.4 billion